RE: Todays's RNS29 Nov 2022 15:22
It's just accounting changes rather than cashflow changes so if the share price has dropped because of the RNS, it shows how inefficient the market is. However there were a few bits that stood out to me:
Lower profit due to deferral to balance sheet and release over time:
"IFRS 17 also introduces a more stable and predictable profit profile through the CSM release. For L&G, this benefit emerges through the deferral of new business profit and demographic assumption changes to the CSM, which will then be spread and released into profit consistently over the lifetime of the contract. Historically, these two components have made a meaningful contribution to Group operating profit from divisions. Indicatively, the removal of these two components, with an adjustment to reflect the higher anticipated release from the in-force book, would reduce divisional operating profit by c20-25%.[4] We expect Insurance earnings to grow in a more stable and predictable way from this new base. We are confident in our ability to continue to write profitable new annuity and protection business, and therefore to grow the CSM and related profits over time. Indicatively, writing £10bn of UK PRT per annum would result in 6-7% CAGR in related operating profit over five years. This would be higher if we wrote more than £10bn per annum. We continue to see compelling investment opportunities across all our businesses, providing further scope to deliver growth beyond this level."
Dividends up by 5% per year hopefully:
"The Group set out an ambition at its 2020 capital markets day to grow the dividend at 3-6% per annum to FY24[2]. Whilst dividend decisions are made annually, the Board's aim is to continue to grow the dividend at 5% per annum to FY24.[3]"
Forward guidance solid:
"Consistent with the guidance provided at HY22, we expect to deliver resilient FY22 operating profit growth in line with the 8% delivered in H1 (£1.16bn vs £1.08bn) and FY22 capital generation of £1.8bn."